AprilBio Co Documents
Documents
0
Ticker
397030.KQ
ISIN
KR7397030008
AprilBio Co SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
AprilBio Co Documents 2026
This page contains all official documents and SEC filings for AprilBio Co stock (397030.KQ, ISIN: KR7397030008). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of AprilBio Co's regulatory filings.
AprilBio Co Stock analysis
AprilBio Co AprilBio Co Ltd, headquartered in Chuncheon, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on developing long-acting proteins and antibody drugs, primarily engaged in R&D for innovative biopharmaceuticals including antibody therapeutics and long-acting recombinant protein pharmaceuticals. Listed on July 28, 2022, it employs 24 full-time staff in its research and development activities.